Clear Search
·
7 MIN READ

May 31, 2018: National Advocacy Update

Trump administration plan to lower drug prices, compounding from bulk substances and more in the latest AMA national health care advocacy news.

Advocacy Update
·
2 MIN READ

May 17, 2018: Advocacy spotlight on Trump Administration releases drug pricing blueprint

Trump Administration releases drug pricing blueprint; AMA and Federation members are looking into impact on specialty treatments and other concerns.

Advocacy Update
·
1 MIN READ

AMA President Barbe applauds Trump effort on prescription drug prices

The AMA is pleased the Trump administration is moving forward with its effort to address seemingly arbitrary pricing for prescription drugs.

Press Releases
·
7 MIN READ

May 3, 2018: National Advocacy Update

Overhaul of the Meaningful Use program, cuts to in-office clinical testing services and more in the latest AMA national health care advocacy news.

Advocacy Update
7 MIN READ

AMA model bills

View the most frequently used model state bills created for the Federation of Medicine and approved by the AMA Board of Trustees.

State Advocacy
·
3 MIN READ

April 19, 2018: State Advocacy Update

New AMA model state legislation is the latest AMA state advocacy effort.

Advocacy Update
Stethoscopes in the grass illustration.
·
5 MIN READ

Physicians have plenty of tools to help grow advocacy grassroots

A variety of AMA tools help bring physician voices to the table, leverage lawmaker relationships and activate patients on urgent policy issues.

Access to Care
Commentors standing in line at microphone to make a remark.
·
2 MIN READ

Physicians aim to shine light on why drugs cost so much

The AMA will seek to ban unjustified prescription-drug “price gouging” and let pharmacists tell patients when their co-pay exceeds a drug’s cash price.

Public Health
·
2 MIN READ

AMA expands advocacy efforts supporting drug price transparency

Physicians at the AMA's Interim Meeting adopted new policy to expand the scope of its federal, state advocacy efforts to increase transparency of drug pricing.

Press Releases